肿瘤血管标志物CD105的研究及应用进展

被引:5
作者
张英辉 [1 ]
陈素琴 [2 ]
机构
[1] 石家庄市第四医院产科
[2] 河北医科大学附属第二医院妇科
关键词
CD105; 肿瘤; 诊断; 预后; 治疗;
D O I
暂无
中图分类号
R730.4 [肿瘤诊断学];
学科分类号
100214 [肿瘤学];
摘要
CD105是一个特异表达于新生血管内皮的糖蛋白,主要标记具有增殖活性的内皮细胞。肿瘤生长和浸润有赖于血管生成,新生的血管提供给肿瘤组织营养及氧分,为肿瘤组织增殖提供了基础。CD105是肿瘤新生血管的标志物,其标记的微血管密度,优于其他标志物,更能反映肿瘤的增殖状态和预后,血管生成是肿瘤生长和转移的推动力,以CD105为靶向,抑制肿瘤血管生长的治疗肿瘤的方法成为目前研究的热点。
引用
收藏
页码:68 / 70
页数:3
相关论文
共 8 条
[1]
Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma [J].
Kyzas, Panayiotis A. ;
Agnantis, Niki J. ;
Stefanou, Dimitrios .
VIRCHOWS ARCHIV, 2006, 448 (06) :768-775
[2]
Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: Correlation with long-term patient outcome [J].
Dales, JP ;
Garcia, S ;
Andrac, L ;
Carpentier, S ;
Ramuz, O ;
Lavaut, MN ;
Allasia, C ;
Bonnier, P ;
Charpin, C .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (05) :1197-1204
[3]
Endoglin (CD105) expression in endometrial carcinoma [J].
Saad, RS ;
Jasnosz, KM ;
Tung, MY ;
Silverman, JF .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (03) :248-253
[4]
Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis [J].
Tanaka, F ;
Otake, Y ;
Yanagihara, K ;
Kawano, Y ;
Miyahara, R ;
Li, M ;
Ishikawa, S ;
Wada, H .
LUNG CANCER, 2003, 39 (03) :289-296
[5]
Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin [J].
Bredow, S ;
Lewin, M ;
Hofmann, B ;
Marecos, E ;
Weissleder, R .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) :675-681
[6]
Perfusion of99Tcm-labeled CD105Mab into kidneys from patients with renal carcinoma suggests that CD105is a promising vascular target..Costello B;Li C;Duff S;et al;.Int J Cancer.2004,
[7]
Prognostic impact of VEGF; CD31; CD34; and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer..Mineo TC;Ambrogi V;Baldi A;Rabitti C;Bollero P;Vincenzi B;Tonini G;.J Clin Pathol.2004, 06
[8]
Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays..Charpin C; Dales JP; Garcia S; et al;.Clin Cancer Res.2004,